Accelerate Labs
Accelerate Labs has a split purity-focus record, with GHK-Cu, Semaglutide, and Ipamorelin testing strongest while BPC-157, CJC-1295, and Melanotan II drag the profile down. Evidence is recent but clustered in same-day, same-batch sets, so the trajectory looks dispersed rather than consistently improving.
Florida filings and domain records complicate Accelerate Labs’ claimed origin story, while a former official-looking .com now sits for sale. The report also follows a Nevada residential court footprint, GLP-1 code obfuscation, COA scope gaps, and review-incentive signals.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Accelerate Labs rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 6 Sep 2025 | Pass | Ipamorelin Accelerate Labs | lab name | View COA | |||
| 25 Jul 2025 | Fail | BPC-157 Accelerate Labs | lab name | View COA | |||
| 23 Jul 2025 | Fail | Retatrutide Accelerate Labs | lab name | View COA | |||
| 22 Jul 2025 | Pass | Semaglutide Accelerate Labs | lab name | View COA | |||
| 10 Jul 2025 | Pass | GHK-Cu Accelerate Labs | lab name | View COA | |||
| 10 Jul 2025 | Pass | GHK-Cu Accelerate Labs | lab name | View COA | |||
| 16 May 2025 | Fail | Melanotan II Accelerate Labs | lab name | View COA | |||
| 16 May 2025 | Fail | Melanotan II Accelerate Labs | lab name | View COA | |||
| 16 May 2025 | Pass | Ipamorelin Accelerate Labs | lab name | View COA | |||
| 16 May 2025 | Pass | Retatrutide Accelerate Labs | lab name | View COA | |||
About Accelerate Labs test results from Finnrick
Accelerate Labs is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 20 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Accelerate Labs peptides in this dataset are Semaglutide (3 tests) and Melanotan II (2 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 20 recent tests.